英文别名 |
Bromosporine;Carbamic acid, N-[3-methyl-6-[4-methyl-3-[(methylsulfonyl)amino]phenyl]-1,2,4-triazolo[4,3-b]pyridazin-8-yl]-, ethyl ester;Bromorsporine;Bioomosporine;GTPL8234;C17H20N6O4S;Bromosporine, >=98% (HPLC);AOB6807;HMS3653C21;2286AH;s7233;AK175193;A4186;SW219727-1;J3.656.836D;N-[(6-3-Methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyri;Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate;ethyl N-[6-[3-(methanesulfonamido)-4-methylphenyl]-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate;SCHEMBL17359131;MFCD26142669;BDBM50504160;NSC-768126;GLXC-04090;CCG-268692;CHEMBL3133807;AKOS024458332;AS-75091;HY-15815;Ethyl (3-methyl-6-(4-methyl-3-((methylsulfonyl)amino)phenyl)(1,2,4)triazolo(4,3-b)pyridazin-8-yl)carbamate;DA-61904;NCGC00351471-11;CS-3240;ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate;NSC768126;BP-25350;C73098;Bromosporine?;ethyl (3-methyl-6-{4-methyl-3-[(methylsulfonyl)amino]phenyl}[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate;ethyl N-(6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-(1,2,4)triazolo(4,3-b)pyridazin-8-yl)carbamate;BRD-K44665581-001-01-8;Q27075529;BB170570;ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate;1619994-69-2;Carbamic acid, N-(3-methyl-6-(4-methyl-3-((methylsulfonyl)amino)phenyl)-1,2,4-triazolo(4,3-b)pyridazin-8-yl)-, ethyl ester |